Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
74.12
-0.05 (-0.07%)
At close: Nov 20, 2025, 4:00 PM EST
74.23
+0.11 (0.15%)
After-hours: Nov 20, 2025, 6:45 PM EST
Hologic Market Cap
Hologic has a market cap or net worth of $16.52 billion as of November 20, 2025. Its market cap has decreased by -15.04% in one year.
Market Cap
16.52B
Enterprise Value
16.94B
1-Year Change
-15.04%
Ranking
Category
Stock Price
$74.12
Market Cap Chart
Since December 1, 1998, Hologic's market cap has increased from $167.20M to $16.52B, an increase of 9,781.42%. That is a compound annual growth rate of 18.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 16.53B | 1.06% |
| Dec 31, 2024 | 16.36B | -4.60% |
| Dec 29, 2023 | 17.15B | -6.76% |
| Dec 30, 2022 | 18.39B | -4.46% |
| Dec 31, 2021 | 19.25B | 2.84% |
| Dec 31, 2020 | 18.72B | 33.70% |
| Dec 31, 2019 | 14.00B | 17.78% |
| Dec 31, 2018 | 11.89B | 0.86% |
| Dec 29, 2017 | 11.79B | 5.59% |
| Dec 30, 2016 | 11.16B | 1.98% |
| Dec 31, 2015 | 10.95B | 46.89% |
| Dec 31, 2014 | 7.45B | 22.07% |
| Dec 31, 2013 | 6.10B | 14.36% |
| Dec 31, 2012 | 5.34B | 15.86% |
| Dec 30, 2011 | 4.61B | -5.80% |
| Dec 31, 2010 | 4.89B | 30.76% |
| Dec 31, 2009 | 3.74B | 11.69% |
| Dec 31, 2008 | 3.35B | -61.07% |
| Dec 31, 2007 | 8.60B | 244.89% |
| Dec 29, 2006 | 2.49B | 48.24% |
| Dec 30, 2005 | 1.68B | 195.02% |
| Dec 31, 2004 | 570.40M | 64.62% |
| Dec 31, 2003 | 346.50M | 45.10% |
| Dec 31, 2002 | 238.80M | 62.34% |
| Dec 31, 2001 | 147.10M | 79.39% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 938.41B |
| Johnson & Johnson | 492.51B |
| AbbVie | 407.17B |
| UnitedHealth Group | 282.89B |
| AstraZeneca | 277.11B |
| Novartis AG | 239.24B |
| Merck & Co. | 236.11B |
| Abbott Laboratories | 216.19B |